S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
Log in

Array Biopharma News Headlines (NASDAQ:ARRY)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range N/A
50-Day Range
$47.85
MA: $47.85
$47.85
52-Week Range N/A
Volume206,508 shs
Average Volume4.99 million shs
Market Capitalization$10.68 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.7

Headlines

Array Biopharma (NASDAQ ARRY) News Headlines

Source:
DateHeadline
Array BioPharma Announces Strategic Collaboration with PfizerArray BioPharma Announces Strategic Collaboration with Pfizer
www.bloomberg.com - February 11 at 1:10 PM
Prem Watsa Exits 4 Stocks, Trims 1 PositionPrem Watsa Exits 4 Stocks, Trims 1 Position
finance.yahoo.com - November 22 at 12:35 PM
5 Large-Cap Stocks Are Up More Than 100% This Year5 Large-Cap Stocks Are Up More Than 100% This Year
finance.yahoo.com - November 4 at 1:12 PM
Whats in Store for Array BioPharma (ARRY) in Q4 Earnings?What's in Store for Array BioPharma (ARRY) in Q4 Earnings?
finance.yahoo.com - July 29 at 9:44 PM
Pfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With MylanPfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With Mylan
finance.yahoo.com - July 29 at 4:41 PM
Pfizer stock down after revenue miss, merger announcementPfizer stock down after revenue miss, merger announcement
finance.yahoo.com - July 29 at 9:31 AM
Array BioPharma (ARRY) Moves to Buy: Rationale Behind the UpgradeArray BioPharma (ARRY) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - July 25 at 12:14 PM
Gilead Buys More Galapagos, Callon Acquires Carrizo; Confirming XBI And XOP ETF StrategiesGilead Buys More Galapagos, Callon Acquires Carrizo; Confirming XBI And XOP ETF Strategies
seekingalpha.com - July 15 at 4:52 PM
Here's Why Array BioPharma Soared 75.4% in JuneHere's Why Array BioPharma Soared 75.4% in June
finance.yahoo.com - July 10 at 10:39 AM
Here's Why Blueprint Medicines Stock Rose 75% in the First Half of 2019Here's Why Blueprint Medicines Stock Rose 75% in the First Half of 2019
finance.yahoo.com - July 10 at 10:39 AM
Rigrodsky & Long, P.A. Files Class Action Suit Against Array BioPharma Inc.Rigrodsky & Long, P.A. Files Class Action Suit Against Array BioPharma Inc.
finance.yahoo.com - July 10 at 10:39 AM
Heres Why Array BioPharma Soared 75.4% in JuneHere's Why Array BioPharma Soared 75.4% in June
www.fool.com - July 10 at 8:34 AM
Notable ETF Outflow Detected - IWO, ARRY, DECK, NSPNotable ETF Outflow Detected - IWO, ARRY, DECK, NSP
www.nasdaq.com - July 9 at 4:34 PM
Legal Investigation Alert: Halper Sadeh LLP Continues Investigating Whether the Sale of Array BioPharma Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ARRYLegal Investigation Alert: Halper Sadeh LLP Continues Investigating Whether the Sale of Array BioPharma Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ARRY
finance.yahoo.com - July 9 at 11:03 AM
Array Bios triplet therapy extends survival in late-stage CRC studyArray Bio's triplet therapy extends survival in late-stage CRC study
seekingalpha.com - July 8 at 10:35 AM
Pfizer Is Looking Pretty Smart With Array BioPharma PurchasePfizer Is Looking Pretty Smart With Array BioPharma Purchase
finance.yahoo.com - July 8 at 10:35 AM
Array BioPharma Announces Interim Analysis...Array BioPharma Announces Interim Analysis...
www.benzinga.com - July 6 at 10:03 AM
Array BioPharma Announces Interim Analysis Results from the BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal CancerArray BioPharma Announces Interim Analysis Results from the BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal Cancer
www.prnewswire.com - July 6 at 6:55 AM
ARRY, RTN, DATA and MDSO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MergersARRY, RTN, DATA and MDSO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
finance.yahoo.com - June 27 at 4:31 PM
Lifshitz & Miller LLP Announces Investigation of Array BioPharma Inc., C&J Energy Services, Inc., Liberty Expedia Holdings, Inc., and Raytheon Company, Shutterfly, Inc., Sothebys and Stewardship Financial Corporation, and Zimmer Biomet Holdings, Inc.Lifshitz & Miller LLP Announces Investigation of Array BioPharma Inc., C&J Energy Services, Inc., Liberty Expedia Holdings, Inc., and Raytheon Company, Shutterfly, Inc., Sotheby's and Stewardship Financial Corporation, and Zimmer Biomet Holdings, Inc.
finance.yahoo.com - June 27 at 4:31 PM
Pfizer: This Blue Chip DGI Name Strengthens Its Pipeline With Array BioPharmaPfizer: This Blue Chip DGI Name Strengthens Its Pipeline With Array BioPharma
seekingalpha.com - June 25 at 8:33 AM
Array BioPharma to Present Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E- Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal CancerArray BioPharma to Present Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E- Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal Cancer
finance.yahoo.com - June 25 at 8:33 AM
Notable ETF Inflow Detected - XBI, ARRY, MRTX, EXASNotable ETF Inflow Detected - XBI, ARRY, MRTX, EXAS
www.nasdaq.com - June 21 at 4:23 PM
Is Pfizer Overpaying for Array Biopharma?Is Pfizer Overpaying for Array Biopharma?
finance.yahoo.com - June 20 at 11:02 AM
Pfizer-Array Deal: Growth And Pipeline AdditionPfizer-Array Deal: Growth And Pipeline Addition
seekingalpha.com - June 19 at 10:24 AM
Big Drugmakers That May Tread the M&A Path After PfizerBig Drugmakers That May Tread the M&A Path After Pfizer
finance.yahoo.com - June 19 at 10:24 AM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Array BioPharma AcquisitionSHAREHOLDER ALERT: WeissLaw LLP Investigates Array BioPharma Acquisition
www.prnewswire.com - June 18 at 6:05 PM
Why Pfizers Acquisition of Array BioPharma Wont Pay Off Anytime SoonWhy Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon
www.fool.com - June 17 at 10:06 PM
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Array BioPharma Inc. (NASDAQ: ARRY) on Behalf of Array Shareholders and Encourages Array Investors to Contact the FirmBragar Eagel & Squire, P.C. is Investigating the Board of Directors of Array BioPharma Inc. (NASDAQ: ARRY) on Behalf of Array Shareholders and Encourages Array Investors to Contact the Firm
finance.yahoo.com - June 17 at 10:06 PM
Mid-Day Market Update: Sothebys Jumps On Acquisition News; Flex Pharma Shares SlideMid-Day Market Update: Sotheby's Jumps On Acquisition News; Flex Pharma Shares Slide
www.nasdaq.com - June 17 at 4:45 PM
Pfizer acquires Array in 2nd major Boulder bioscience merger this monthPfizer acquires Array in 2nd major Boulder bioscience merger this month
finance.yahoo.com - June 17 at 4:45 PM
Pfizer Is Buying Array Pharma, Seeking to Broaden Lineup of Cancer DrugsPfizer Is Buying Array Pharma, Seeking to Broaden Lineup of Cancer Drugs
www.barrons.com - June 17 at 12:07 PM
How Much Is Pfizer Overpaying For Array Bio?How Much Is Pfizer Overpaying For Array Bio?
247wallst.com - June 17 at 12:07 PM
Pfizer to buy cancer dug maker Array BioPharma for $10.64 billionPfizer to buy cancer dug maker Array BioPharma for $10.64 billion
www.marketwatch.com - June 17 at 12:07 PM
Pfizer To Buy Array BioPharma For $48/SharePfizer To Buy Array BioPharma For $48/Share
www.benzinga.com - June 17 at 12:07 PM
Pfizer buys cancer treatment innovator Array BioPharma for $11 billionPfizer buys cancer treatment innovator Array BioPharma for $11 billion
www.bizjournals.com - June 17 at 12:07 PM
Pfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug SpecialistPfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug Specialist
www.thestreet.com - June 17 at 12:07 PM
Pfizer to acquire Array BiopharmaPfizer to acquire Array Biopharma
seekingalpha.com - June 17 at 12:07 PM
Array BioPharma spikes more than 50% after Pfizer shells out $11 billion for the cancer-drug developerArray BioPharma spikes more than 50% after Pfizer shells out $11 billion for the cancer-drug developer
www.businessinsider.com - June 17 at 12:07 PM
Stocks mixed as Fed meeting comes into viewStocks mixed as Fed meeting comes into view
finance.yahoo.com - June 17 at 12:07 PM
Array Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Array BioPharma Inc. is Fair to Shareholders – ARRYArray Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Array BioPharma Inc. is Fair to Shareholders – ARRY
finance.yahoo.com - June 17 at 12:07 PM
"Merger Monday" Returns: Pfizer Buying Array, T-Mobile-Sprint on Ice?"Merger Monday" Returns: Pfizer Buying Array, T-Mobile-Sprint on Ice?
finance.yahoo.com - June 17 at 12:07 PM
ARRAY BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutARRAY BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
finance.yahoo.com - June 17 at 12:07 PM
Big Ticket Mergers Are in FocusBig Ticket Mergers Are in Focus
finance.yahoo.com - June 17 at 12:07 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Array BioPharma Inc. to Pfizer Inc. is Fair to ShareholdersSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Array BioPharma Inc. to Pfizer Inc. is Fair to Shareholders
finance.yahoo.com - June 17 at 12:07 PM
Why Array BioPharma Stock Is on Fire TodayWhy Array BioPharma Stock Is on Fire Today
www.fool.com - June 17 at 10:26 AM
4 Price Momentum Stocks Hedge Funds Love Could Be Big Summer Winners4 Price Momentum Stocks Hedge Funds Love Could Be Big Summer Winners
www.msn.com - June 12 at 2:22 PM
Here is What Hedge Funds Think About Array Biopharma Inc (ARRY)Here is What Hedge Funds Think About Array Biopharma Inc (ARRY)
finance.yahoo.com - June 10 at 11:21 AM
Why Is Array BioPharma (ARRY) Up 27.1% Since Last Earnings Report?Why Is Array BioPharma (ARRY) Up 27.1% Since Last Earnings Report?
finance.yahoo.com - June 6 at 11:28 AM
Array BioPharma to Present at the Goldman Sachs 40ᵗʰ Annual Global Healthcare ConferenceArray BioPharma to Present at the Goldman Sachs 40ᵗʰ Annual Global Healthcare Conference
finance.yahoo.com - June 4 at 4:25 PM
This page was last updated on 3/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel